Absolute neutrophil count (ANC) >= /mm^ (after granulocyte colony-stimulating factor [G-CSF] discontinued)
Absolute neutrophil count (ANC) ?.  e/L, hemoglobin (Hb) ?. g/dL, and platelet count ?.  e/L independent of transfusion of red blood cells (RBC) or platelet concentrates and independent of granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF).
Neutrophil count ? ,/mm without granulocyte colony stimulating factor.
Absolute neutrophil count >= ,/mcL; red blood cell (RBC) transfusions and use of granulocyte colony-stimulating factor (G-CSF) will be allowed in order to meet eligibility parameters (unless dysfunction is secondary to lymphoma involvement)
Absolute neutrophil count (ANC) >=  x ^/L, unsupported by granulocyte colony-stimulating factor (G-CSF) or granulocytes (within  days of study registration)
White blood cell (WBC) > . x ^/L with an absolute neutrophil count (ANC) > . x ^/L off granulocyte colony-stimulating factor (G-CSF) or granulocyte macrophage colony-stimulating factor (GM-CSF) for  days or Neulasta for  days
Absolute neutrophil count >  cells/mm^ (. x ^/L) independent of transfusion and growth factor support for at least  days prior to screening (except for pegylated granulocyte-colony stimulating factor [G-CSF] [pegfilgrastim] and darbepoetin which require at least  days prior to screening)
FULL STUDY INCLUSION CRITERIA: Absolute neutrophil count (ANC) >= /mm^, without biologic response modifiers, such as granulocyte colony-stimulating factor (G-CSF), within  weeks before the start of study treatment
Absolute neutrophil count (ANC) >=  K/mm^ (without use of granulocyte colony-stimulating factor [G-CSF]  weeks prior to enrollment)
Absolute neutrophil count (ANC) >= /mcl (granulocyte-colony stimulating factor [G-CSF] is allowed) (must be within  days of MLA)
Absolute neutrophil count (ANC) >=  x ^/L unsupported by granulocyte-stimulating growth factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) for  days
Absolute neutrophil count (ANC) ? . x ^/L without granulocyte colony-stimulating factor (G-CSF) support within  days preceding the lab assessment.
Absolute neutrophil count ? ,/mm (excluding measurements obtained within  days after administration of granulocyte colony-stimulating factor [G-CSF]).
Absolute neutrophil count (ANC) >= /uL; granulocyte colony-stimulating factor receptor (G-CSF) is not permitted within  days of screening
Absolute neutrophil count (ANC) >= /mm^ (patients should be off granulocyte colony-stimulating factor [G-CSF] for at least  days)
Absolute neutrophil count (ANC) > . x ^/L off granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) for  days or Neulasta for  days
Absolute neutrophil count (ANC) ? .  /L. Screening of ANC should be independent of granulocytecolony stimulating factor (G-CSF) support for at least one week and of pegylated G-CSF for at least two weeks.
Absolute neutrophil count (ANC) >= /mm^ (without use of granulocyte colony-stimulating factor [G-CSF]  weeks prior to enrollment)
Absolute neutrophil count (ANC) >= . x ^/L within  days prior to cycle  day , without granulocyte-colony stimulating factor (G-CSF)
Absolute neutrophil count (ANC) >= . x ^/L within  days of time of consent, without granulocyte- colony stimulating factor (G-CSF)
Absolute neutrophil count (ANC) >= . x ^/L within  days prior to randomization independent of granulocyte colony-stimulating factor (G-CSF) for >=  week and pegylated G-CSF for >=  weeks
Engraftment of neutrophils (absolute neutrophil count [ANC] >= . X ^/L) for  days without granulocyte colony-stimulating factor (g-csf) support
Absolute neutrophil count (ANC) >= /mm^ (without granulocyte colony-stimulating factor [G-CSF] support within  weeks prior to cycle , day )
Absolute neutrophil count >= ,/mcL (in the absence of granulocyte colony stimulating factor (GCSF) for >=  days)
